Author:
Hartog Christiane S.,Reinhart Konrad
Publisher
Springer International Publishing
Reference94 articles.
1. Anonymous. Commission implementing decision. Brussels, 19.12.2013 c(2013)9793 (final). http://ec.europa.eu/health/documents/community-register/2013/20131219127286/dec_127286_en.pdf.
2. Anonymous. Assessment report for solutions for infusion containing hydroxyethyl starch. Procedure under article 107i of directive 2001/83/EC. http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Hydroxyethyl_starch-containing_medicines_107/Recommendation_provided_by_Pharmacovigilance_Risk_Assessment_Committee/WC500154254.pdf.
3. Finfer S, Liu B, Taylor C, Bellomo R, Billot L, Cook D, et al. Resuscitation fluid use in critically ill adults: an international cross sectional study in 391 intensive care units. Crit Care. 2010;14(5):R185.
4. Avorn J. Learning about the safety of drugs – a half-century of evolution. N Engl J Med. 2011;365(23):2151–3.
5. Maio G. On the history of the contergan (thalidomide) catastrophe in the light of drug legislation. Dtsch Med Wochenschr. 2001;126(42):1183–6.